New Heart Pill Cuts Inflammation 86% in Early Trial

An experimental pill designed to prevent heart disease slashed dangerous inflammation levels by 86% in just three weeks, offering fresh hope for millions at cardiovascular risk.

The early results mark another breakthrough in treating chronic conditions through inflammation control.